Givastomig, a CLDN18.2 x 4-1BB bispecific antibody, continues to show robust efficacy when combined with nivolumab and ...
Glomus tumours are uncommon, typically benign neoplasms of specialised dermal thermoregulatory structures known as glomus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback